What is ICU Medical's stock price target for 2024?

0 equities research analysts have issued 12 month target prices for ICU Medical's shares. Their ICUI share price targets range from $216.00 to $216.00. On average, they expect the company's stock price to reach $216.00 in the next year. This suggests a possible upside of 136.5% from the stock's current price. View analysts price targets for ICUI or view top-rated stocks among Wall Street analysts .

How have ICUI shares performed in 2023?

ICU Medical's stock was trading at $157.48 at the beginning of the year. Since then, ICUI stock has decreased by 42.0% and is now trading at $91.34. View the best growth stocks for 2023 here .

When is ICU Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, February 26th 2024. View our ICUI earnings forecast .

How were ICU Medical's earnings last quarter?

ICU Medical, Inc. (NASDAQ:ICUI) posted its earnings results on Monday, November, 6th. The medical instruments supplier reported $1.23 EPS for the quarter, beating the consensus estimate of $0.94 by $0.29. The medical instruments supplier earned $553.31 million during the quarter, compared to the consensus estimate of $554 million. ICU Medical had a positive trailing twelve-month return on equity of 6.53% and a negative net margin of 1.25%.

What ETFs hold ICU Medical's stock?

ETFs with the largest weight of ICU Medical (NASDAQ:ICUI) stock in their portfolio include SPDR S&P Health Care Equipment ETF (XHE) , Principal Healthcare Innovators ETF (BTEC) and Fidelity Disruptive Medicine ETF (FMED) .

What is Vivek Jain's approval rating as ICU Medical's CEO?

81 employees have rated ICU Medical Chief Executive Officer Vivek Jain on Glassdoor.com . Vivek Jain has an approval rating of 73% among the company's employees.

What other stocks do shareholders of ICU Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ICU Medical investors own include Becton, Dickinson and Company (BDX) , BlackRock (BLK) , NVIDIA (NVDA) , Alibaba Group (BABA) , CA (CA) , UnitedHealth Group (UNH) , Boeing (BA) , Micron Technology (MU) , Lockheed Martin (LMT) and ServiceNow (NOW) .

Who are ICU Medical's major shareholders?

ICU Medical's stock is owned by many different retail and institutional investors. Top institutional shareholders include Wellington Management Group LLP (6.58%), FMR LLC (4.66%), Fuller & Thaler Asset Management Inc. (4.20%), JPMorgan Chase & Co. (3.01%), Morgan Stanley (2.70%) and Victory Capital Management Inc. (2.62%). Insiders that own company stock include Christian B Voigtlander, Daniel Woolson, Elisha W Finney , George A Lopez , Robert S Swinney , Virginia Ruth Sanzone and Vivek Jain . View institutional ownership trends .

How do I buy shares of ICU Medical?

Shares of ICUI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull , Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here .

ICU Medical Stock Price, News & Analysis (NASDAQ:ICUI)

$91.34

+3.58 (+4.08%)

(As of 12/1/2023 ET)

Compare

Today's Range: $85.68
▼
$91.54
50-Day Range: $81.08
▼
$119.29
52-Week Range: $78.28
▼
$212.43

Volume: 479,129 shs
Average Volume: 638,455 shs
Market Capitalization: $2.20 billion

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $216.00

ICU Medical MarketRank™ Stock Analysis

Analyst Rating: 0.00 Rating Score
Upside/Downside: 136.5% Upside
$216.00 Price Target
Short Interest: Bearish
6.27% of Float Sold Short
Dividend Strength: N/A
Sustainability: -1.47
Upright™ Environmental Score
News Sentiment: 0.74
Based on 4 Articles This Week
Insider Trading: Selling Shares
$1.04 M Sold Last Quarter
Proj. Earnings Growth: 11.39%
From $5.18 to $5.77 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.95 out of 5 stars

Medical Sector

657th out of 957 stocks

Surgical & Medical Instruments Industry

70th out of 92 stocks

2.0

Analyst's Opinion

Price Target Upside/Downside
According to analysts' consensus price target of $216.00, ICU Medical has a forecasted upside of 136.5% from its current price of $91.34.
Amount of Analyst Coverage
ICU Medical has received no research coverage in the past 90 days.

2.0

Short Interest

Percentage of Shares Shorted
6.27% of the float of ICU Medical has been sold short.
Short Interest Ratio / Days to Cover
ICU Medical has a short interest ratio ("days to cover") of 5.6.
Change versus previous month
Short interest in ICU Medical has recently decreased by 4.51%, indicating that investor sentiment is improving.

0.0

Dividend Strength

Dividend Yield
ICU Medical does not currently pay a dividend.
Dividend Growth
ICU Medical does not have a long track record of dividend growth.

3.9

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
ICU Medical has received a 52.01% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Intravenous therapy equipment", "Catheters", and "Parenteral (intravenous) nutrition formulations" products. See details.
Environmental Sustainability
The Environmental Impact score for ICU Medical is -1.47.

2.6

News and Social Media Coverage

News Sentiment
ICU Medical has a news sentiment score of 0.74. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
News Coverage This Week
MarketBeat has tracked 4 news articles for ICU Medical this week, compared to 2 articles on an average week.
Search Interest
4 people have searched for ICUI on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.

2.5

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, ICU Medical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,036,128.00 in company stock.
Percentage Held by Insiders
Only 7.50% of the stock of ICU Medical is held by insiders.
Percentage Held by Institutions
91.49% of the stock of ICU Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.3

Earnings and Valuation

Earnings Growth
Earnings for ICU Medical are expected to grow by 11.39% in the coming year, from $5.18 to $5.77 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of ICU Medical is -78.07, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of ICU Medical is -78.07, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
ICU Medical has a P/B Ratio of 1.05. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About ICU Medical Stock (NASDAQ:ICUI)

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; and ClearGuard HD, that maintains hemodialysis catheters. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 brand; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform that connects smart pumps to hospital's electronic health records, asset tracking systems, and alarm notification platforms; professional services; critical care products, such as Cogent 2-in-1 and CardioFlo hemodynamic monitoring systems; TDQ and OptiQ cardiac output monitoring catheters; TriOx venous oximetry catheters; Transpac blood pressure transducers; and SafeSet closed blood sampling and conservation systems. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is headquartered in San Clemente, California.

ICUI Stock Price History

30 days | 90 days | 365 days | Advanced Chart

ICUI Stock News Headlines

November 29, 2023 | finance.yahoo.com

Is ICU Medical, Inc. (NASDAQ:ICUI) Trading At A 50% Discount?

November 27, 2023 | finance.yahoo.com

Carlyle Group and WP Carey Set to Join S&P MidCap 400; Others to Join S&P SmallCap 600

December 3, 2023 | Wealthpress (Ad)

Trading Experts Call It “The Perfect Tesla Trade”

Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.

November 8, 2023 | seekingalpha.com

ICU Medical: Who Is Coming To The Rescue?

November 7, 2023 | msn.com

ICU Medical Stock Plunged Today - Here's Why

November 7, 2023 | insidermonkey.com

ICU Medical, Inc. (NASDAQ:ICUI) Q3 2023 Earnings Call Transcript

November 7, 2023 | finanznachrichten.de

ICU Medical, Inc.: ICU Medical Announces Third Quarter 2023 Results

November 6, 2023 | finance.yahoo.com

ICU Medical Announces Third Quarter 2023 Results

December 3, 2023 | DTI Trader (Ad)

All the trading advice you’ve ever received boils down to this

All the trading advice you’ve ever received boils down to one goal and one goal only: finding a reliable edge in the markets. If you can do that, grab hold of it and never let go. Because once you have that edge, and you can count on it, you never need to do anything else.

November 6, 2023 | finance.yahoo.com

ICU Medical Inc (ICUI) Reports Q3 2023 Earnings: Revenue Down 7.5%, Net Income Turns Positive

November 3, 2023 | msn.com

JFRD unveils brand new critical care unit with lifesaving, ‘advanced medical equipment’

October 30, 2023 | msn.com

Critical care: Lack of beds, VVIP culture hitting PGI dept functioning

October 26, 2023 | finance.yahoo.com

ICU Medical Inc (IC7.MU)

October 23, 2023 | finance.yahoo.com

ICU Medical Announces Time of Third Quarter 2023 Earnings Conference Call

October 5, 2023 | finance.yahoo.com

ICU Medical (NASDAQ:ICUI) investors are sitting on a loss of 54% if they invested five years ago

September 25, 2023 | finance.yahoo.com

Do Options Traders Know Something About ICU Medical (ICUI) Stock We Don't?

September 12, 2023 | benzinga.com

ICU Medical Chief Operating Officer Trades Company's Stock

September 12, 2023 | finance.yahoo.com

Insider Sell: Christian Voigtlander Sells 6,850 Shares of ICU Medical Inc

September 5, 2023 | finance.yahoo.com

ICU Medical to Participate at the Morgan Stanley 21st Annual Global Healthcare Conference

August 29, 2023 | marketwatch.com

ICU Medical Gets FDA Clearance for Infusion Pump-Software Combo

August 29, 2023 | finance.yahoo.com

ICU Medical Receives FDA Clearance for Plum Duo™ Infusion Pump and LifeShield™ Infusion Safety Software

August 21, 2023 | seekingalpha.com

ICU Medical: Continued Disappointments

August 9, 2023 | finance.yahoo.com

ICU Medical, Inc. (NASDAQ:ICUI) Q2 2023 Earnings Call Transcript

August 8, 2023 | finanznachrichten.de

ICU Medical, Inc.: ICU Medical Announces Second Quarter 2023 Results and Narrows Fiscal Year 2023 Guidance Ranges

August 8, 2023 | markets.businessinsider.com

ICU Medical Q2 Earnings Summary

August 8, 2023 | finance.yahoo.com

ICU Medical Announces Second Quarter 2023 Results and Narrows Fiscal Year 2023 Guidance Ranges

August 8, 2023 | finance.yahoo.com

ICU Medical (ICUI) Beats Q2 Earnings Estimates

See More Headlines

Receive ICUI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ICU Medical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 11/06/2023
Today: 12/03/2023
Fiscal Year End: 12/31/2023
Next Earnings (Estimated): 2/26/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Surgical & medical instruments
Sub-Industry: Health Care Supplies
Sector: Medical
Current Symbol: NASDAQ:ICUI
CUSIP: 44930G10
CIK: 883984
Web: www.icumed.com
Phone: (949) 366-2183
Fax: 949-366-8368
Employees: 14,500
Year Founded: 1984

Price Target and Rating

Average Stock Price Target: $216.00
High Stock Price Target: $216.00
Low Stock Price Target: $216.00
Potential Upside/Downside: +136.5%
Consensus Rating
Rating Score (0-4): 0.00
Research Coverage: 0 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($1.17)
Trailing P/E Ratio: N/A
Forward P/E Ratio: 17.63
P/E Growth: N/A
Net Income: $-74,290,000.00
Net Margins: -1.25%
Pretax Margin: -2.80%
Return on Equity: 6.53%
Return on Assets: 3.08%

Debt

Debt-to-Equity Ratio: 0.76
Current Ratio: 2.63
Quick Ratio: 0.99

Sales & Book Value

Annual Sales: $2.28 billion
Price / Sales: 0.97
Cash Flow: $16.46 per share
Price / Cash Flow: 5.55
Book Value: $86.92 per share
Price / Book: 1.05

Miscellaneous

Outstanding Shares: 24,140,000
Free Float: 22,330,000
Market Cap: $2.20 billion
Optionable: Optionable
Beta: 0.63

Social Links

Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives

Mr. Vivek Jain (Age 51)
CEO & Chairman of the Board
Comp: $1.16M
Mr. Brian Michael Bonnell (Age 49)
CFO & Treasurer
Comp: $618.92k
Mr. Christian B. Voigtlander (Age 54)
Chief Operating Officer
Comp: $651.42k
Ms. Virginia Ruth Sanzone (Age 48)
Corporate VP, General Counsel, Secretary & Compliance Officer
Comp: $552.73k
Clay Fradd
Corporate Vice President of Human Resources

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

ICUI Stock Analysis - Frequently Asked Questions

What is ICU Medical's stock price target for 2024?: 0 equities research analysts have issued 12 month target prices for ICU Medical's shares. Their ICUI share price targets range from $216.00 to $216.00. On average, they expect the company's stock price to reach $216.00 in the next year. This suggests a possible upside of 136.5% from the stock's current price.
View analysts price targets for ICUI or view top-rated stocks among Wall Street analysts.
How have ICUI shares performed in 2023?: ICU Medical's stock was trading at $157.48 at the beginning of the year. Since then, ICUI stock has decreased by 42.0% and is now trading at $91.34.
View the best growth stocks for 2023 here.
When is ICU Medical's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, February 26th 2024.
View our ICUI earnings forecast.
How were ICU Medical's earnings last quarter?: ICU Medical, Inc. (NASDAQ:ICUI) posted its earnings results on Monday, November, 6th. The medical instruments supplier reported $1.23 EPS for the quarter, beating the consensus estimate of $0.94 by $0.29. The medical instruments supplier earned $553.31 million during the quarter, compared to the consensus estimate of $554 million. ICU Medical had a positive trailing twelve-month return on equity of 6.53% and a negative net margin of 1.25%.
What ETFs hold ICU Medical's stock?: ETFs with the largest weight of ICU Medical (NASDAQ:ICUI) stock in their portfolio include SPDR S&P Health Care Equipment ETF (XHE), Principal Healthcare Innovators ETF (BTEC) and Fidelity Disruptive Medicine ETF (FMED).

What is Vivek Jain's approval rating as ICU Medical's CEO?: 81 employees have rated ICU Medical Chief Executive Officer Vivek Jain on Glassdoor.com. Vivek Jain has an approval rating of 73% among the company's employees.
What other stocks do shareholders of ICU Medical own?: Based on aggregate information from My MarketBeat watchlists, some companies that other ICU Medical investors own include Becton, Dickinson and Company (BDX), BlackRock (BLK), NVIDIA (NVDA), Alibaba Group (BABA), CA (CA), UnitedHealth Group (UNH), Boeing (BA), Micron Technology (MU), Lockheed Martin (LMT) and ServiceNow (NOW).
Who are ICU Medical's major shareholders?: ICU Medical's stock is owned by many different retail and institutional investors. Top institutional shareholders include Wellington Management Group LLP (6.58%), FMR LLC (4.66%), Fuller & Thaler Asset Management Inc. (4.20%), JPMorgan Chase & Co. (3.01%), Morgan Stanley (2.70%) and Victory Capital Management Inc. (2.62%). Insiders that own company stock include Christian B Voigtlander, Daniel Woolson, Elisha W Finney, George A Lopez, Robert S Swinney, Virginia Ruth Sanzone and Vivek Jain.
View institutional ownership trends.
How do I buy shares of ICU Medical?: Shares of ICUI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:ICUI) was last updated on 12/3/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial